NCT07572136
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Acute Lymphoblastic Leukemia
Explore clinical trials studying Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
471 public trials
116 recruiting studies
Acute Lymphoblastic Leukemia trial results
Not Yet Recruiting
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
NCT07710781
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
- Locations
-
Not specified
Not Yet Recruiting
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not Yet Recruiting
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
NCT07634653
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia, +19 more
- Locations
-
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Not Yet Recruiting
CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia
NCT07623655
- Conditions
- Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
- Locations
-
Not specified
Not Yet Recruiting
Phase I Study of FXS0683 in the Treatment of Blood Tumors
NCT07616089
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
NCT07192237
- Conditions
- Acute Lymphoblastic Leukemia, Blinatumomab, Hematologic Diseases, +11 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not Yet Recruiting
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
NCT07483749
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +14 more
- Locations
-
- Children's hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- Hangzhou Children's Hospital Hangzhou, Zhejiang, China
- Affiliated Women and Children's Hospital of Ningbo University Ningbo, Zhejiang, China
Not Yet Recruiting
Treatment for Ph-negative ALL for Adults up to 65 Years
NCT07443592
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Hospital de A Coruña A Coruña, Spain
- Hospital Universitario de Araba Alava, Spain
- Hospital General Universitario de Albacete Albacete, Spain
- Hospital General Universitario Dr. Balmis Alicante, Spain